CORRESP Filing
Axe Compute Inc.
Date: July 24, 2025 · CIK: 0001446159 · Accession: 0001171843-25-004690
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288782
Letter
PREDICTIVE ONCOLOGY INC.
91 43rd Street, Suite 110
Pittsburgh, PA 15201
July 24, 2025
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Margaret Sawicki
Re: Predictive Oncology Inc.
Acceleration Request for Registration Statement on Form S-1
File No. 333-288782
Requested Date: July 28, 2025
Requested Time: 5:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Predictive Oncology Inc. (the " Registrant ") hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-288782) (the " Registration Statement ") be declared effective at the "Requested Date" and "Requested Time" set forth above, or as soon as practicable thereafter, or at such later time as the Registrant or its counsel may orally request (the " Registration Statement Acceleration Request ") via telephone call to the staff (the " Staff ") of the Division of Corporation Finance of the Securities and Exchange Commission (the " Commission "). The Registrant hereby authorizes Amanda Maki of DLA Piper LLP (US), counsel for the Registrant, to make such request on the Registrant's behalf.
We request that we be notified of the effectiveness of the Registration Statement by telephone to Amanda Maki at 713-425-8461. Thank you for your assistance.
Very truly yours,
/s/ Josh Blacher
Show Raw Text
CORRESP 1 filename1.htm PREDICTIVE ONCOLOGY INC. 91 43rd Street, Suite 110 Pittsburgh, PA 15201 July 24, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Margaret Sawicki Re: Predictive Oncology Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-288782 Requested Date: July 28, 2025 Requested Time: 5:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Predictive Oncology Inc. (the " Registrant ") hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-288782) (the " Registration Statement ") be declared effective at the "Requested Date" and "Requested Time" set forth above, or as soon as practicable thereafter, or at such later time as the Registrant or its counsel may orally request (the " Registration Statement Acceleration Request ") via telephone call to the staff (the " Staff ") of the Division of Corporation Finance of the Securities and Exchange Commission (the " Commission "). The Registrant hereby authorizes Amanda Maki of DLA Piper LLP (US), counsel for the Registrant, to make such request on the Registrant's behalf. We request that we be notified of the effectiveness of the Registration Statement by telephone to Amanda Maki at 713-425-8461. Thank you for your assistance. Very truly yours, /s/ Josh Blacher Josh Blacher Interim Chief Financial Officer cc: Raymond Vennare (Chief Executive Officer, Predictive Oncology Inc.) Sara Turken (General Counsel, Predictive Oncology Inc.) Amanda Maki (DLA Piper LLP (US))